Mean creatinine decrease after administration of intravenous contrast in patients with renal dysfunction:...

Area of Science:

• Nephrology
• Radiology
• Pharmacology

Background:

• Contrast nephropathy risk is often assessed using threshold-based increases in serum creatinine (SCr), which can be misleading.
• This traditional method overlooks creatinine decreases and continuous renal function data, potentially overestimating contrast-induced acute kidney injury (AKI) risk.
• Analyzing mean SCr changes offers a more accurate assessment of contrast's impact on renal function.

Purpose of the Study:

• To analyze published data for calculating mean SCr changes following intravenous contrast administration.
• To evaluate the significance of these mean SCr changes in patients with pre-existing renal dysfunction.

Main Methods:

• Systematic review of 14 publications involving 2057 patients with pre-existing renal dysfunction.
• Inclusion criteria specified modern contrast agents, dose, and availability of SCr means and standard deviations pre- and post-contrast.
• Analysis focused on mean SCr changes and their statistical significance at various post-contrast intervals.

Main Results:

• Mean SCr decreased significantly from 148.6 µmol/L pre-contrast to 144.1 µmol/L post-contrast.
• Significant SCr reductions were observed at 4, 7, and 10 days post-contrast, particularly in patients receiving hydration.
• Only 6.6% of patients met traditional study-defined thresholds for contrast nephropathy.

Conclusions:

• The observed slight, significant SCr improvement suggests that contrast-induced AKI risk estimates may have been erroneously high.
• The risk of clinically significant AKI after contrast is unlikely in patients with moderate renal failure.
• Mean post-contrast SCr decline should guide clinical decisions, and future studies should analyze mean changes, variation, and significance.